Sort by
Refine Your Search
-
commitment to contribute to the academic community at the Political Theory Working Group and at the Department of Political Science (required). The PhD Program The PhD program provides PhD students with strong
-
programme, please see: For SCIENCE www.science.ku.dk/phd , “Study Structures” Until the MSc degree is obtained, (when exactly two years of the full 3+5 programme remains), the grant will be paid partly in
-
team of ambitious scientists, where both excellence in science and team-spirit are the primary objectives. The team includes PhD students, postdocs, scholar students as well as bachelor and master
-
spectrometry, and untargeted data science workflows. Proficiency in chemometric methods and/or python programming will be an advantage. Candidates are expected to be enthusiastic and adaptable to working in
-
collaboration, as part of the employment process at the University of Copenhagen. Notice: In the following description of the PhD programmes, some references are made to SCIENCE websites The PhD programme
-
preferably has strong programming skills and experience with the modeling and simulations of fluid or solid mechanics or ice sheet flow and deformation (for example by use of finite element/volume methods
-
group is focused on developing new computational methods for the prediction of chemical reactivity. The group is a part of Department of Chemistry, Faculty of SCIENCE, University of Copenhagen. We
-
The Novo Nordisk Foundation Quantum Computing Programme (NQCP) is establishing a talented and diverse international team to create a cutting-edge quantum programme in the heart of Copenhagen
-
more than 1300 Danish 6-11-year-old children. This included food and nutrition intervention components in the form of a school lunch programme, activities in the local supermarkets and SFO and practical tools
-
sciences and advancing vaccine development. NIVI-R conducts scientific research, while NIVI-D works to quickly turn that research into new vaccine candidates. NIVI-D accelerates clinical trials (phases 1 and